GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality

PURPOSE To assess the association between the Oncotype DX Genomic Prostate Score (GPS) result and longterm oncological outcomes following radical prostatectomy (RP).